Recombinant Zebrafish ARL4CA

• Cat.No.: ARL4CA-2498Z
• Product Overview: Recombinant Zebrafish ARL4CA full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Zebrafish
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: arl4ca ADP-ribosylation factor-like 4Ca [ Danio rerio (zebrafish) ]
• Official Symbol: ARL4CA
• Gene ID: 550444
• mRNA Refseq: NM_001017749
• Protein Refseq: NP_001017749
• UniProt ID: Q561U6

Reviews

03/26/2023

the ARL4CA protein stands out for its exceptional quality and its ability to fulfill my experimental requirements.

04/12/2022

Their extensive technical expertise and assistance are invaluable in overcoming any challenges that may arise during the experimental process.

09/18/2020

the ARL4CA protein comes highly recommended for its exceptional performance in Western blot analysis and its utility in protein electron microscopy structure analysis.

11/02/2018

the manufacturer's commitment to customer satisfaction extends beyond technical support. They offer a comprehensive range of related products and resources to aid researchers in their trials.

03/05/2018

From troubleshooting to optimizing experimental protocols, the manufacturer provides diligent support to ensure the success of the trial.

02/17/2018

The versatility of the ARL4CA protein extends beyond these applications, enabling its use in a wide range of experimental techniques.

01/13/2018

Its compatibility with various methodologies further enhances its value as a research tool, making it a go-to choice for investigating ARL4CA protein function and molecular interactions.

08/16/2017

This property is particularly beneficial for long-term trials or experiments with extended durations, ensuring consistent performance throughout the entire study period.

Q&As

Is ARL4CA expressed in different tissues compared to ARL4C?

The tissue-specific expression pattern of ARL4CA may differ from ARL4C, depending on the regulatory elements present within the alternatively spliced region. It might have distinct expression in certain tissues or cell types.

Does ARL4CA interact with the same proteins as ARL4C?

ARL4CA is expected to have similar protein interactions as ARL4C since it shares a substantial sequence similarity. However, the additional amino acid residues might enable unique protein interactions as well.

Are there any disease associations or mutations related to ARL4CA?

Given its status as an isoform of ARL4C, it is plausible that ARL4CA may share similar disease associations and mutations. However, further research is needed to specifically determine the disease relevance and functional differences of ARL4CA.

How is the expression of ARL4CA regulated in cells?

The regulatory mechanisms governing the expression of ARL4CA likely follow similar principles as ARL4C. Transcriptional regulation, alternative splicing, and post-translational modifications can influence the expression levels and activity of ARL4CA in cells.

Can ARL4CA be targeted for therapeutic purposes?

The therapeutic potential of targeting ARL4CA, specifically, is currently unknown due to limited research. However, if ARL4CA exhibits distinct functions or disease-relevant roles, it might be a potential target for therapeutic interventions.